Jonathan Bramson

Founder and Chief Scientific Officer at Triumvira Immunologics

Dr. Jonathan Bramson founded Triumvira Immunologics, Inc., along with his post-doctoral Fellow, Dr. Christopher Helsen, in 2015. He is currently a Professor in the Department of Pathology and Molecular Medicine and the Vice Dean (Research) for the Faculty of Health Sciences at McMaster University. He holds a Tier I Canada Research Chair in Translational Cancer Immunology and the John Bienestock Chair in Molecular Medicine. As an immunologist who has been researching novel cancer immune-oncology strategies since 1994, Dr. Bramson’s lab is focused on developing methods to direct cancer patients’ immune systems to attack their tumors. To this end, the lab has been developing novel methods to engineer T cells to attack cancer and designing vaccines based on recombinant viruses to boost immunity against specific tumor antigens. The Bramson lab works closely with clinical partners at the Juravinski Hospital in Hamilton to optimally develop these exciting new immune strategies to address unmet needs of the cancer community in Southern Ontario. Together, Dr. Bramson and his colleagues have established an infrastructure at McMaster, which includes GMP production and GLP correlative assays, for conducting clinical trials of novel immune-oncology therapies that are unparalleled in Canada. Dr. Bramson received his Ph.D. in Experimental Medicine in 1994 from McGill University.

Roles

  • Founder and Chief Scientific Officer

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.